Advanced Cancer Therapeutics (ACT) is leading innovation within the biotechnology industry. Founded in January 2007, the company is focused on the discovery and early development of novel cancer therapeutics as well as selection for partnership, commercialization and manufacture of the most promising discoveries. Utilizing its groundbreaking business arrangement with the James Graham Brown Cancer Center and the University of Louisville Research Foundation, ACT will establish exclusive rights to specific novel therapeutics and fast-track these leading edge discoveries to the pharmaceutical industry, and ultimately the patients who need them.
View Top Employees from Advanced Cancer Therapeutics (ACT)| Website | http://www.advancedcancertherapeutics.com |
| Revenue | $3 million |
| Funding | $10 million |
| Employees | 1 (0 on RocketReach) |
| Founded | 2007 |
| Address | 300 E Market St Ste 280, Louisville, Kentucky 40202, US |
| Phone | (502) 589-6404 |
| Fax | (502) 589-6391 |
| Technologies |
JavaScript,
HTML,
ASP.NET
+3 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Life Science, Therapeutics, Health Care |
| Competitors | AbbVie, Gilead Sciences, Novartis Healthcare Pvt. Ltd., OncoMed Incorporated, Pfizer |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies |
Looking for a particular Advanced Cancer Therapeutics (ACT) employee's phone or email?
Advanced Cancer Therapeutics (ACT) Questions
The Advanced Cancer Therapeutics (ACT) annual revenue was $3 million in 2023.
Advanced Cancer Therapeutics (ACT) is based in Louisville, Kentucky.
The NAICS codes for Advanced Cancer Therapeutics (ACT) are [541, 541713, 54171, 5417, 54].
The SIC codes for Advanced Cancer Therapeutics (ACT) are [87, 873].
Related Companies
